4.5 Article

Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Serial OX40 Engagement on CD4+ T Cells and Natural Killer T Cells Causes Allergic Airway Inflammation

Triya Damayanti et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Review Immunology

Control of Immunity by the TNFR-Related Molecule OX40 (CD134)

Michael Croft

ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)

Article Multidisciplinary Sciences

NIP45 controls the magnitude of the type 2 T helper cell response

John W. Fathman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Immunology

Transgenic Mice Expressing Dominant-Negative Bright Exhibit Defects in B1 B Cells

Jamee C. Nixon et al.

JOURNAL OF IMMUNOLOGY (2008)

Review Oncology

Opinion - Survivin, cancer networks and pathway-directed drug discovery

Dario C. Altieri

NATURE REVIEWS CANCER (2008)

Article Medicine, Research & Experimental

In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation

Dhaya Seshasayee et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination

VP Badovinac et al.

NATURE MEDICINE (2005)

Article Immunology

Analysis of the susceptibility of CD57+ T cells to CD3-mediated apoptosis

N Shinomiya et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)

Article Immunology

OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation

S Salek-Ardakani et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)

Article Biochemistry & Molecular Biology

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53

WH Hoffman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)